"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

SANTA CLARA, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today unveiled the highly-anticipated AMD RDNA™ 4 graphics architecture with the launch of the AMD Radeon™ RX 9070 XT and RX ...

Framework has announced a substantial upgrade for the Framework Laptop 13, highlighted by the powerful AMD Ryzen AI 300 ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Jio Platforms Limited (JPL), together with AMD, Cisco, and Nokia, announced at Mobile World Congress 2025 plans to form an ...

The Gigabyte AMD Radeon RX 9070 is part of the new Radeon 9000 GPU lineup. With support for the new RNDA 4 architecture, 3rd ...

Intel just announced an expansion of its Core Ultra (Series 2) processor family of devices to include more chips with vPro.

AMD CEO Lisa Su is confident in the company's AI dominance, fueled by growth in AI GPUs, server CPUs, and strategic ...

PlayStation console architect Mark Cerny recently told Eurogamer that Sony plans to integrate the neural network behind AMD's FSR4 upscaler into the PlayStation 5 Pro's PSSR ...

The proposal would see TSMC run Intel's foundry division operations, but it would not own more than 50%, Reuters writes. The Trump administration does not want ...

AMD really came out swinging with the Radeon RX 9070 XT. At $599, it undercuts the Nvidia Geforce RTX 5070 Ti by a whopping ...